在肝细胞癌中批准的免疫检查点抑制剂:一个大规模的元分析和系统审查
Ruyi Zhang1,2, Fang Wang2, Zhiyu You1
1Department of Clinical Laboratory, First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guizhou, 550001, China.
Journal of cancer research and clinical oncology
|February 6, 2024
概括
免疫检查点抑制剂 (ICI) 对肝细胞癌 (HCC) 患者的治疗结果有所改善,包括整体存活率和无进展存活率. 虽然有效,但在HCC治疗方面仍需要进一步改进.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 肝细胞癌研究 肝细胞癌研究
背景情况:
- 肝细胞癌 (HCC) 仍然是一个重大的全球健康挑战.
- 免疫检查点抑制剂 (ICI) 已成为治疗各种癌症的有希望的治疗策略,包括HCC.
结论:
- 经批准的ICI证明了HCC治疗的显著益处和可接受的安全性.
- 对肝细胞癌的向治疗来说,ICI具有优势.
- 基于ICI的HCC疗法有可能进一步进步.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
778
相关概念视频
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K